This gene encodes a protease inhibitor that regulates the tissue factor (TF)-dependent pathway of blood coagulation. The coagulation process initiates with the formation of a factor VIIa-TF complex, which proteolytically activates additional proteases (factors IX and X) and ultimately leads to the formation of a fibrin clot. The product of this gene inhibits the activated factor X and VIIa-TF proteases in an autoregulatory loop. The encoded protein is glycosylated and predominantly found in the vascular endothelium and plasma in both free forms and complexed with plasma lipoproteins. Several alternatively spliced transcript variants of this gene have been described, but the full-length nature of some of these variants has not been confirmed. [provided by RefSeq, Jul 2008].
Ranasinghe, Duke, Harvie, McManus: "Kunitz-type protease inhibitor as a vaccine candidate against schistosomiasis mansoni." in: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, Vol. 66, pp. 26-32, (2018) (PubMed).
Gustafson, Shepherd, Miller, Jayachandran: "Age- and sex-specific differences in blood-borne microvesicles from apparently healthy humans." in: Biology of sex differences, Vol. 6, pp. 10, (2015) (PubMed).
Hansen, Petersen, Lauritzen, Clausen, Grell, Agersø, Sørensen, Hilden, Almholt: "Target-mediated clearance and bio-distribution of a monoclonal antibody against the Kunitz-type protease inhibitor 2 domain of Tissue Factor Pathway Inhibitor." in: Thrombosis research, Vol. 133, Issue 3, pp. 464-71, (2014) (PubMed).
Wun, Kretzmer, Girard, Miletich, Broze: "Cloning and characterization of a cDNA coding for the lipoprotein-associated coagulation inhibitor shows that it consists of three tandem Kunitz-type inhibitory domains." in: The Journal of biological chemistry, Vol. 263, Issue 13, pp. 6001-4, (1988) (PubMed).